An FDA-approved device that delivers transcranial single-pulse magnetic stimulation significantly reduces the number of migraine headache days per month, potentially providing a nondrug prevention option.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.
Leave a Reply